Anavitarte Tracker
2021-2022 RegularYeaUpdated August 30, 2026Industry-specific subsidies

HB 304

Revenue and taxation; medical equipment and supplies manufacturers and pharmaceutical and medicine manufacturers; provide tax credit

Created a direct tax credit for selected medical-equipment and pharmaceutical manufacturers.

Why a local resident might care

This is the clearest type of selective subsidy in the tracker: a direct tax preference for chosen manufacturers rather than a generally available tax cut.

Bill → beneficiary → local effect

HB 304→Medical-equipment and pharmaceutical manufacturers→Public cost unclear

What the bill did

Created a tax credit for qualifying medical equipment and supplies manufacturers and pharmaceutical and medicine manufacturers.

Who benefits

Selected manufacturers in the medical-equipment and pharmaceutical sectors.

Estimated public cost

No clear bill-specific fiscal estimate found in public sources reviewed.

Public sources reviewed did not isolate a reliable bill-specific cost estimate.

Confidence and evidenceTap to expand

High confidence. Cleanest, strongest examples with direct business-facing benefit and strong documentary support.

This item is classified as a clearer business-benefit item because the benefit is business-facing and the public-interest case is weaker or more indirect.

Related questions

Sources

More to read

Related bills in the same pattern